OncoMatch/Clinical Trials/NCT07773688
Two-photon Fluorescence Microscopy of Dermatologic Biopsies
Is NCT07773688 recruiting? Yes, currently enrolling (Sep 2026). This NA trial studies Two photon microscopy imaging for basal cell carcinoma of skin.
Treatment: Two photon microscopy imaging — The goal of this study is to investigate the ability of two-photon fluorescence microscopy to evaluate dermatologic biopsies. The main questions it aims to answer are: • How well do two-photon fluorescence images of biopsies taken in a clinic and evaluated by a pathologist agree with conventional histology?
Check if I qualifyEligibility summary
For patients with basal cell carcinoma of skin, melanocytic lesion, adult or squamous cell carcinoma.
This summary was generated by AI from the trial's official eligibility criteria and may contain errors. Always confirm with the study team before contacting a site.
US trial sites
- Rochester Dermatologic Surgery · Victor, New York
Showing up to 5 US sites.
See all sites on ClinicalTrials.gov →Frequently asked questions
Is NCT07773688 currently recruiting?
Yes, this trial is currently recruiting patients.
Could you qualify for this trial?
Enter your biomarker results to see how this trial's eligibility criteria match your specific cancer profile.
Check if I qualify